Pulmonx Corp

LUNG Nasdaq SEC CIK 1127537
Follow Pulmonx Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $22.8M +6.2% vs same quarter last year
Net income −$8.4M +39.9% vs same quarter last year
EPS, diluted −$0.19 +44.1% vs same quarter last year
Operating cash flow −$3.2M +61% vs same quarter last year
Revenue by quarter
$23.8M
$22.5M
$23.9M
$21.5M
$22.6M
$20.6M
$22.8M
$22.8M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income9 fiscal years
  • Revenue
  • Net income
−$100M−$50M$0$50M$100MFY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$90.5M−$54M
FY24$83.8M−$56.4M
FY23$68.7M−$60.8M
FY22$53.7M−$58.9M
FY21$48.4M−$48.7M
FY20$32.7M−$32.2M
FY19$32.6M−$20.7M
FY18$20M−$18.5M
FY17--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−150%−100%−50%0%50%100%FY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2574.2%−59.3%−59.7%
FY2474%−68.9%−67.3%
FY2373.9%−90.2%−88.6%
FY2274.3%−109.3%−109.8%
FY2173.6%−97.7%−100.5%
FY2064.8%−98.8%−98.5%
FY1968.8%−54.7%−63.5%
FY1861.4%−75.2%−92.4%
FY17---
Free cash flowOperating cash flow minus capital expenditure
−$60M−$40M−$20M$0FY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$32.8M
FY24−$33M
FY23−$38.4M
FY22−$46.4M
FY21−$45.1M
FY20−$31.5M
FY19−$21.5M
FY18−$18.7M
FY17-
Returned to shareholdersDividends paid and shares bought back
$0$10K$20K$30KFY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearBuybacks
FY25-
FY24-
FY23$0
FY22$27K
FY21$26K
FY20$21K
FY19$12K
FY18$0
FY17-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Pulmonx
  • Healthcare median
−150%−100%−50%0%FY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearPulmonxHealthcare median
FY25−59.7%−30.6%
FY24−67.3%−47%
FY23−88.6%−58%
FY22−109.8%−80.4%
FY21−100.5%−71.8%
FY20−98.5%−62.2%
FY19−63.5%−46.2%
FY18−92.4%−49.6%
FY17-−45.9%